advertisement
11.3.4 Betablocker (7)
Showing records 1 to 7
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker16773 Evaluation of the β2-adrenergic receptor gene as a candidate glaucoma gene in 2 ancestral populations
McLaren N; Reed DM; Musch DC; Downs CA; Higashi ME; Santiago C; Radenbaugh PA; Allingham RR; Richards JE; Moroi SE
Archives of Ophthalmology 2007; 125: 105-111
16907 Effect and mechanism of βxolol and timolol on vascular relaxation in isolated rabbit ciliary artery
Dong Y; Ishikawa H; Wu Y; Shimizu K; Goseki T; Yoshitomi T
Japanese Journal of Ophthalmology 2006; 50: 504-508
17165 Allergic contact dermatitis due to (β)-blockers in eye drops: A retrospective analysis of multicentre surveillance data 1993-2004
Jappe U; Uter W; Menezes De Padua CA; Herbst RA; Schnuch A
Acta Dermato-Venereologica 2006; 86: 509-514
17186 Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension: Part 1
Kanno M; Araie M; Masuda K; Takase M; Kitazawa Y; Shiose Y; Azuma I; Ogawa N; Ohdo S
Arzneimittel-Forschung/Drug Research 2006; 56: 729-734
16837 Latanoprost versus timolol gel-forming solution once daily in primary open-angle glaucoma or ocular hypertension
Harasymowycz P; Hutnik CM; Nicolela M; Stewart WC
Canadian Journal of Ophthalmology 2007; 42: 75-81
16796 A 6-month assessment of bimatoprost 0.03% vs timolol maleate 0.5%: hypotensive efficacy, macular thickness and flare in ocular-hypertensive and glaucoma patients
Martin E; Martinez-de-la-Casa JM; Garcia-Feijoo J; Troyano J; Larrosa JM; Garcia-Sanchez J
Eye 2007; 21: 164-168
17176 Effect of switching from aqueous timolol to gel-forming timolol ophthalmic solution
Inoue K; Sogabe M; Wakakura M; Inouye J; Tomita G
Japanese Journal of Clinical Ophthalmology 2006; 60: 1971-1976
